Cargando…
Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422189/ https://www.ncbi.nlm.nih.gov/pubmed/30899436 http://dx.doi.org/10.18632/oncotarget.26767 |
_version_ | 1783404347519926272 |
---|---|
author | Eyre, Toby A. |
author_facet | Eyre, Toby A. |
author_sort | Eyre, Toby A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6422189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-64221892019-03-21 Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? Eyre, Toby A. Oncotarget Correction Impact Journals LLC 2019-02-26 /pmc/articles/PMC6422189/ /pubmed/30899436 http://dx.doi.org/10.18632/oncotarget.26767 Text en Copyright: © 2019 Eyre et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Eyre, Toby A. Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
title | Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
title_full | Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
title_fullStr | Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
title_full_unstemmed | Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
title_short | Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
title_sort | correction: predictive biomarkers for disease sensitivity in lymphoma – the holy grail for hdac inhibitors? |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422189/ https://www.ncbi.nlm.nih.gov/pubmed/30899436 http://dx.doi.org/10.18632/oncotarget.26767 |
work_keys_str_mv | AT eyretobya correctionpredictivebiomarkersfordiseasesensitivityinlymphomatheholygrailforhdacinhibitors |